2018
DOI: 10.1016/j.bioorg.2018.08.008
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis of 1H-1,2,3-triazole derivatives as new α-glucosidase inhibitors and their molecular docking studies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
46
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 86 publications
(46 citation statements)
references
References 44 publications
0
46
0
Order By: Relevance
“…13), exhibited activity against the target enzyme, which was the best among all the synthesised triazole derivatives, with IC 50 value of 14.2 µM in inhibition of the α-glucosidase enzyme. 133 Moreover, molecular modelling analysis revealed that 104 displayed a preferential binding mode by interacting with three active site residues Arg312, Glu304, and Phe158, which suggested that further developments of 104 may provide new lead compounds as antidiabetic drugs.…”
Section: Antidiabetic Activitymentioning
confidence: 99%
“…13), exhibited activity against the target enzyme, which was the best among all the synthesised triazole derivatives, with IC 50 value of 14.2 µM in inhibition of the α-glucosidase enzyme. 133 Moreover, molecular modelling analysis revealed that 104 displayed a preferential binding mode by interacting with three active site residues Arg312, Glu304, and Phe158, which suggested that further developments of 104 may provide new lead compounds as antidiabetic drugs.…”
Section: Antidiabetic Activitymentioning
confidence: 99%
“…[2][3][4][5][6][7] The structural framework of 1,2,3-triazole enables it to mimic different functional groups, justifying its wide use as a bioisostere for the synthesis of new active molecules possessing a broad range of biological activities that include antimicrobial, anticancer, and antiviral, along with antidiabetic, anti-inammatory, anti-Alzheimer, and antioxidant properties. 8,9 All these methodologies have permitted the successful design of novel drug analogs via combinatorial synthesis.…”
Section: Introductionmentioning
confidence: 99%
“…Phen is a well-known enzyme inhibitor (McCann et al, 2012;Boumans et al, 1997;Sartorius et al, 1988) and copper-dca À complexes (Cui et al, 2011) were found to be urease active, whereas a tin-dca À complex (Saeed et al, 2010) showed some antibacterial and antifungal activity (vide supra). As an extension of our search for new potential -glucosidase and urease inhibitors (Avula et al, 2018;Ur Rehman et al, 2018;Arfan et al, 2010), we were interested in comparing the bioactivities of alkali/alkaline earth complexes of phen/dcaH. Complexes 1-3 were evaluated in in-vitro assays against urease and -glucosidase enzyme for inhibition studies using the literature-reported protocol (Choudhary et al, 2010;Arfan et al, 2010).…”
Section: Urease and A-glucosidase Enzyme Inhibitionmentioning
confidence: 99%
“…Notably, two mononuclear copper complexes (Cui et al, 2011) were found to be urease active, whereas a tetranuclear tin complex (Saeed et al, 2010) showed some antibacterial and antifungal activity. As a continuation of our search for new potential -glucosidase and urease inhibitors (Avula et al, 2018;Ur Rehman et al, 2018;Alam et al, 2019), we were interested in the bioactivities of alkali/alkaline earth complexes of phen/dcaH.…”
Section: Introductionmentioning
confidence: 99%